These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21960538)

  • 1. Doors of deception: the diaspora of designer drugs.
    Kerwin J
    Drug Test Anal; 2011 Sep; 3(9):527-31. PubMed ID: 21960538
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Platteborze PL; Martin TM
    Mil Med; 2013 Jan; 178(1):v. PubMed ID: 23356108
    [No Abstract]   [Full Text] [Related]  

  • 3. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on cannabinoids and synthetic cannabinoids.
    Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
    Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G; Hurst D; Penn A; Yung K
    Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cannabis.
    Westin AA; Brede WR; Espnes KA
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2289. PubMed ID: 23736197
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemistry, pharmacology, and metabolism of emerging drugs of abuse.
    Maurer HH
    Ther Drug Monit; 2010 Oct; 32(5):544-9. PubMed ID: 20683389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cannabinoids: a new frontier of designer drugs.
    Gunderson EW
    Ann Intern Med; 2013 Oct; 159(8):563-4. PubMed ID: 24018791
    [No Abstract]   [Full Text] [Related]  

  • 14. Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
    Seely KA; Prather PL; James LP; Moran JH
    Mol Interv; 2011 Feb; 11(1):36-51. PubMed ID: 21441120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoids: analysis and metabolites.
    Elsohly MA; Gul W; Wanas AS; Radwan MM
    Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new drug war.
    Underwood E
    Science; 2015 Jan; 347(6221):469-73. PubMed ID: 25635069
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of naphthoylindoles acting on cannabinoid receptors based on their fragmentation patterns under ESI-QTOFMS.
    Sekuła K; Zuba D; Stanaszek R
    J Mass Spectrom; 2012 May; 47(5):632-43. PubMed ID: 22576877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.